CURE.DE vs. QDVG.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and QDVG.DE (iShares S&P 500 Health Care Sector UCITS ETF (Acc)) are both Health & Biotech Equities funds - CURE.DE tracks the MVIS Global Future Healthcare ESG while QDVG.DE tracks the S&P 500 Capped 35/20 Health Care. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 3.69%/yr for QDVG.DE. At a 0.50 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.15%/yr for QDVG.DE.
Performance
CURE.DE vs. QDVG.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than QDVG.DE's -1.02% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
QDVG.DE
- 1D
- 2.86%
- 1M
- 5.52%
- YTD
- -1.02%
- 6M
- -0.40%
- 1Y
- 13.47%
- 3Y*
- 3.69%
- 5Y*
- 6.75%
- 10Y*
- 8.96%
CURE.DE vs. QDVG.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -4.35% |
QDVG.DE iShares S&P 500 Health Care Sector UCITS ETF (Acc) | -1.02% | 1.65% | 8.47% | -1.74% | 1.08% |
Correlation
The correlation between CURE.DE and QDVG.DE is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.54 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.47 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | 0.50 |
The correlation between CURE.DE and QDVG.DE has been stable across timeframes, ranging from 0.47 to 0.54 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. QDVG.DE — Risk / Return Rank
CURE.DE
QDVG.DE
CURE.DE vs. QDVG.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | QDVG.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.60 | ||
| Sortino ratioReturn per unit of downside risk | -0.85 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.16 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 1.21 | -0.91 |
| Martin ratioReturn relative to average drawdown | 0.68 | 2.96 | -2.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | QDVG.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 0.89 | -0.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.46 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.56 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.48 | -0.62 |
Drawdowns
CURE.DE vs. QDVG.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, which is greater than QDVG.DE's maximum drawdown of -26.77%. Use the drawdown chart below to compare losses from any high point for CURE.DE and QDVG.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | QDVG.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -26.77% | -8.03% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -10.74% | -8.33% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -22.70% | -6.62% |
Max Drawdown (5Y)Largest decline over 5 years | — | -22.70% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.77% | — |
Current DrawdownCurrent decline from peak | -15.66% | -7.31% | -8.35% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -5.35% | -9.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 4.41% | +4.12% |
Volatility
CURE.DE vs. QDVG.DE - Volatility Comparison
VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a higher volatility of 5.73% compared to iShares S&P 500 Health Care Sector UCITS ETF (Acc) (QDVG.DE) at 5.24%. This indicates that CURE.DE's price experiences larger fluctuations and is considered to be riskier than QDVG.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | QDVG.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 5.24% | +0.49% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 10.23% | +4.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 14.70% | +5.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 14.48% | +6.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 15.77% | +4.97% |
CURE.DE vs. QDVG.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is higher than QDVG.DE's 0.15% expense ratio.
Dividends
CURE.DE vs. QDVG.DE - Dividend Comparison
Neither CURE.DE nor QDVG.DE has paid dividends to shareholders.
Frequently Asked Questions
CURE.DE and QDVG.DE have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, QDVG.DE is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
QDVG.DE is cheaper with a 0.15% expense ratio, compared with 0.35% for CURE.DE.
CURE.DE tracks MVIS Global Future Healthcare ESG, while QDVG.DE tracks S&P 500 Capped 35/20 Health Care. They also come from different issuers: VanEck and iShares. Their fees differ too: 0.35% for CURE.DE and 0.15% for QDVG.DE.
Find the right allocation for CURE.DE and QDVG.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer